New Breakthrough in Alzheimer’s Diagnosis: Early Detection and Management Strategies Discussed by Neurology Expert

Alzheimer’s disease is a progressive neurodegenerative disorder that affects memory and cognitive abilities, leading to dementia in later stages. The condition is caused by the accumulation of abnormal protein deposits called amyloid in the brain, which disrupt nerve cell communication. Traditional methods of diagnosis include medical history review and cognitive assessments, but new biological markers can now accurately diagnose early-stage Alzheimer’s disease.

Prof. David Tana, an expert in neurology, emphasizes the importance of early detection in the management of drug therapy and lifestyle changes to delay the progression of the disease. Alzheimer’s disease is the leading cause of dementia in old age, affecting a large number of individuals in Israel and projected to triple by 2050.

The new test is available for people over the age of 18 who have been referred by a doctor for cognitive testing. The price of the amyloid test is 3,450 dinars, and it can be combined with additional tests for treatment with specific drugs or genetic prediction of the disease. Most private health insurance in Israel now covers the test, and it is expected to be subsidized by health funds soon.

In addition to information about the Alzheimer’s test, the website has a variety of resources and links, ranging from wedding planning to event workshops to cooking recipes. Users can explore topics from writing services to web hosting to sports forums, offering a diverse range of content for different interests and needs.